The company — a 2020 RealLIST Startups honoree — aims to treat open-angle glaucoma with an ocular implant that’s designed to remove excess fluid from inside the eye. Its recent funding injection totals just over $4 million.
RealLIST Startups 2020 honoree Avisi Technologies, maker of an ocular implant to treat glaucoma, is the recent recipient of a $1 million Small Business Innovation Research Phase II grant from the National Science Foundation (NSF) — funds cofounder Rui Jing Jiang said will go toward bringing the startup’s research to life in preclinical work.
25 Mid-Atlantic companies will be showcasing their products, including a handful of Philly tech companies such […]
The inaugural cohort of JPOD resident companies, which J&J will support in various capacities from concept to commercialization. The seven early-stage startups are treating glaucoma, reconstructing peripheral nerves, developing brain stimulation therapies, and much, much more.
